COST-EFFECTIVENESS OF ALENDRONATE THERAPY FOR OSTEOPENIC POSTMENOPAUSAL WOMEN IN JAPAN

被引：0
|
作者：
Moriwaki, K. [1 ]
Komaba, H. [2 ]
Noto, S. [1 ]
Yanagisawa, S. [3 ]
Inoue, H. [1 ]
Takeshi, T. [1 ]
Fukagawa, M. [2 ]
Takahashi, H. E. [1 ]
机构：
[1] Niigata Univ Hlth & Welf, Niigata, Japan
[2] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan
[3] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Himeji, Hyogo, Japan
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.260
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A46 / A47
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women
    Schousboe, JT
    Nyman, JA
    Kane, RL
    Ensrud, KE
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (09) : 734 - 741
  • [2] Cost-Effectiveness of Alendronate for the Treatment of Osteopenic Postmenopausal Women in Japan
    Moriwaki, Kensuke
    Komaba, Hirotaka
    Noto, Shinichi
    Yanagisawa, Shinichiro
    Takiguchi, Toru
    Inoue, Hiroki
    Toujo, Takeshi
    Fukagawa, Masafumi
    Takahashi, Hideaki E.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (02) : 395 - 403
  • [3] COST-EFFECTIVENESS OF ALENDRONATE THERAPY FORCORTICOSTEROID-INDUCED OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH RHEUMATOID ARTHRITIS IN JAPAN
    Moriwaki, K.
    Noto, S.
    Inoue, H.
    Yanagisawa, S.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A447 - A447
  • [4] Cost-effectiveness of alendronate in the treatment of postmenopausal women in the UK
    Borgström, F
    Johnell, O
    Jönsson, B
    Kanis, J
    Kong, SX
    Sen, SS
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S13 - S13
  • [5] COST-EFFECTIVENESS OF BISPHOSPHONATES IN THE PREVENTION OF FRACTURES IN OSTEOPENIC POSTMENOPAUSAL WOMEN IN COLOMBIA
    Diaz-Puentes, M.
    Rosselli, D.
    Colon-Pena, C. -A.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S138 - S139
  • [6] The cost-effectiveness of therapy with Teriparatide and alendronate in women with severe osteoporosis
    Liu, Hau
    Michaud, Kaleb
    Nayak, Smita
    Karpf, David B.
    Owens, Douglas K.
    Garber, Alan M.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (11) : 1209 - 1217
  • [7] COST-EFFECTIVENESS OF DENOSUMAB COMPARED WITH GENERIC ALENDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN
    Hiligsmann, Mickael
    Reginster, Jean-Yves
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 112 - 113
  • [8] COST-EFFECTIVENESS OF DENOSUMAB COMPARED WITH GENERIC ALENDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN
    Hiligsmann, M.
    Reginster, J. Y.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A309 - A310
  • [9] Effects of alendronate on osteopenic postmenopausal Chinese women
    Yen, ML
    Yen, BL
    Jang, MH
    Hsu, SHJ
    Cheng, WC
    Tsai, KS
    [J]. BONE, 2000, 27 (05) : 681 - 685
  • [10] Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan
    Mori, T.
    Crandall, C. J.
    Ganz, D. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (05) : 1733 - 1744
12345